Clinical Trials Browser

Phase 2 × Terminated × Fibroblast Growth Factor 7 × Clear all

Lymphoma, T-Cell

NCT00593554 2018-04-10

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies